All Stories

  1. Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission
  2. “Extrafine single inhaler triple therapy effect on health status, lung function and adherence in COPD patients: A Panhellenic prospective non-interventional study – The TRIBUNE study”
  3. Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
  4. Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
  5. Global initiative for chronic obstructive lung disease (GOLD) recommendations: strengths and concerns for future needs
  6. IL-26 in the Lung and Its Role in COPD Inflammation
  7. SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
  8. The Diagnostic Role of Uric Acid to Creatinine Ratio for the Identification of Patients with Adverse Pulmonary Embolism Outcomes
  9. Microalbuminuria on admission for acute exacerbation of COPD as a predictor of all-cause mortality and future exacerbations
  10. Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler® Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study
  11. The Role of Blood Eosinophils in the Management of COPD: An Attempt to Answer the Important Clinical Questions
  12. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
  13. The role of uric acid to creatinine ratio as predictor marker during pulmonary embolism
  14. The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease
  15. Blood eosinophils as predictor of outcomes in patients hospitalized for COPD exacerbations: a prospective observational study
  16. Device use errors among patients with asthma and COPD and the role of training: a real-life study
  17. Serum uric acid and arterial lactate levels in patients with obstructive sleep apnea syndrome: the effect of CPAP treatment
  18. Lactate dehydrogenase, COVID-19 and mortality
  19. Lactate dehydrogenase, COVID-19 and mortality
  20. Identification and treatment of T2-low asthma in the era of biologics
  21. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
  22. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
  23. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation
  24. Serum periostin in patients hospitalized for COPD exacerbations
  25. Duration of Hospitalization and Lung Function Deterioration as Predictors of Future Chronic Obstructive Pulmonary Disease Exacerbations
  26. The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit
  27. Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?
  28. Prediction of Hospitalization Stay in COPD Exacerbations: The AECOPD-F Score
  29. Collateral Damage: Depressive Symptoms in the Partners of COPD Patients
  30. Serum uric acid as a predictor of mortality and future exacerbations of COPD
  31. Novel Anti-Inflammatory Agents in COPD: Targeting Lung and Systemic Inflammation
  32. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations
  33. Statins and outcome after hospitalization for COPD exacerbation: A prospective study
  34. Vibration Response Imaging: evaluation of rater agreement in healthy subjects and subjects with pneumonia